9 Hot Takes from JPM24 – MedCity News
I travel to a lot of the major conferences in the healthcare world, but I didn’t make it to this year’s J.P. Morgan Healthcare Conference in San Francisco. Because we all have FOMO from…
Continue Reading
Tag: Life Sciences
13 Potential Blockbuster Drugs and Gamechangers to Watch in 2024
What You Should Know:
– Clarivate Plc, a provider of trusted information and insights, today unveiled its highly anticipated 2024 Drugs to Watch report, shining a spotlight on 13 cutting-edge therapeutics poised to revolutionize healthcare…
Continue Reading
Debiopharm and ThinkingNodeLife.ai Partner on AI-Driven Cancer Drug Development
What You Should Know:
– Debiopharm, a leading independent biopharmaceutical company, and ThinkingNodeLife.ai (TNL), a pioneer in AI-powered drug discovery, today announced a groundbreaking partnership to propel the development of a cutting-edge cancer drug.
– This…
Continue Reading
Deepcell & NVIDIA Partner to Develop Generative AI Models for Single Cell Morphology
What You Should Know:
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced a research collaboration with NVIDIA to accelerate the development and adoption of advanced computer…
Continue Reading
Clinical Trial Payments: Optimizing the Path Forward for Site Payments
Jim DiCesare, Sr. Director, Study Operations, IQVIA Clinical Trial Payments
Escalating competition for clinical trial sites, in tandem with other industry-wide challenges such as changing regulations; a lack of bandwidth and resources; identifying ideal sites…
Continue Reading
Lessons from the AIDS Crisis to Combat Congenital Syphilis
David Stein, CEO and co-founder of Ash Wellness
Public health learnings and data gathered over the 40 years of the AIDS crisis can help officials tackle the rise of congenital syphilis, which increased 755% from 2012 to 2021 and another 30% in 2022. The…
Continue Reading
Veracyte Acquires C2i Genomics for $70M, Expanding into Minimal Residual Disease Detection
What You Should Know:
– Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
– Under the terms of the agreement, Veracyte will pay $70…
Continue Reading
Caris & Flatiron Team Up: Next-Level RWD Supercharges Cancer Drug Discovery
What You Should Know:
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionise healthcare and improve the human condition using molecular science…
Continue Reading
Amgen Builds Generative AI Models for Human Data Analysis and Drug Discovery
What You Should Know: – Amgen, a global leader in biotechnology, is embarking on a groundbreaking venture: Project Freyja. – The new initiative will harness the power of an NVIDIA DGX SuperPOD, christened after…
Continue Reading
Uber Health, Socially Determined partner to leverage SDOH data
Healthcare data analytics company Socially Determined and Uber Health, the ride-hailing company’s healthcare arm for patients and providers, are partnering to improve access to food and prescription delivery as well as transportation services by…
Continue Reading